Taevas
Hong KongMarket Entry & Growth in Hong Kong
Hong Kong is Asia's premier life-sciences gateway, offering a streamlined regulatory environment under the MDCO and direct access to Greater China and Southeast Asian markets. Taevas delivers end-to-end market entry support so your brand reaches clinician
MDCO Registration
HKDH Import Licence
ISO 13485 Recognised
$22B+
Healthcare Market Size
Top 5
Asia-Pacific Pharma Hub
7.5M+
Population with High Purchasing Power
18
Districts Across Hong Kong
Industries We Support
Four Industries. One Hong Kong Team.
Select an industry to see regulatory pathways, services, and how Taevas supports your Hong Kong market entry.
Medical Devices & Equipment
Medical Device Control Office (MDCO), Department of Health, Hong Kong
Hong Kong's medical device market is valued at over USD 1.5 billion and serves as a critical springboard into Greater China. The Medical Device Control Office (MDCO) administers a risk-based classification system aligned with the IMDRF framework, covering Class I through Class IV devices. Taevas provides full-cycle regulatory and commercial support, from MDCO registration to distributor activation and KOL engagement across Hong Kong's public and private hospital networks.
Regulatory Pathways
Mandatory
MDCO Device Registration
All medical devices sold in Hong Kong must be listed or registered with the MDCO under the Medical Devices Ordinance. Taevas prepares technical dossiers aligned with IMDRF guidelines and manages the full submission lifecycle.
Low to High Risk
Risk Classification Assessment
Devices are classified from Class I (low risk) to Class IV (high risk) based on intended use and risk profile. Taevas conducts pre-submission classification reviews to confirm the correct pathway before dossier preparation begins.
Mandatory
Import and Trader Licence
Importers and traders of medical devices in Hong Kong must hold a valid licence issued by the MDCO. Taevas acts as your licensed local representative and manages all import documentation and customs declarations.
Ongoing
Post-Market Surveillance
Registered device holders must maintain vigilance reporting and field safety corrective action (FSCA) obligations under MDCO requirements. Taevas provides ongoing post-market surveillance management and incident reporting support.
Our Services for Medical Devices in India
Why Taevas Hong Kong
Why Global Brands Choose Taevas for Hong Kong
Taevas combines deep regulatory expertise under the MDCO and Pharmacy and Poisons Board frameworks with an established commercial network spanning Hong Kong's public and private healthcare, retail, and wellness sectors.
Regulatory Depth
MDCO and Board-Registered Expertise
Our Hong Kong regulatory team has direct experience navigating Medical Device Control Office and Pharmacy and Poisons Board submissions across all device classes and drug categories, reducing approval timelines and avoiding costly rejections.
Regional Access
Gateway to Greater China
Hong Kong's unique position as a bridge between international markets and mainland China means a successful Hong Kong entry can accelerate your Greater China strategy. Taevas leverages this positioning to maximise your regional market reach.
Speed to Revenue
Accelerated Time to Market
Our pre-submission advisory, dossier templates, and regulatory authority relationships help life-sciences brands achieve faster approvals and earlier commercial launches in Hong Kong than working through generalist consultants.
Distribution Ready
Established Distributor Network
Taevas maintains active relationships with Hong Kong's leading medical device, pharmaceutical, and health consumer distributors, enabling rapid channel activation across Hospital Authority, private hospital, pharmacy, and retail segments.
KOL Access
KOL and Clinical Network
Our curated network of Hong Kong clinicians, pharmacists, dermatologists, and nutrition specialists provides credible clinical endorsement and peer-to-peer advocacy to drive adoption of your products in key therapeutic and consumer categories.
Proven Results
Proven Track Record in Asia-Pacific
Taevas has supported life-sciences brands from North America, Europe, and Asia in achieving successful Hong Kong market entry, with a consistent record of on-time registrations and commercial milestones across devices, pharma, and wellness.
Get Started
Ready to Enter the Hong Kong Market?
Book a free consultation with our Hong Kong market entry specialists and receive a tailored regulatory and commercial roadmap for your life-sciences brand.
Free Hong Kong assessment
MDCO and Pharmacy Board specialists
Distribution network across all 18 districts
End-to-end to revenue